Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli
暂无分享,去创建一个
George Georgiou | Robert Mabry | Thomas Van Blarcom | G. Georgiou | B. Iverson | Yariv Mazor | Brent L Iverson | Y. Mazor | T. V. Blarcom | R. Mabry | Yariv Mazor | T. V. Blarcom
[1] N. Lonberg,et al. High-avidity human IgGκ monoclonal antibodies from a novel strain of minilocus transgenic mice , 1996, Nature Biotechnology.
[2] H. Hoogenboom,et al. Selecting and screening recombinant antibody libraries , 2005, Nature Biotechnology.
[3] Eric T. Boder,et al. Yeast surface display for screening combinatorial polypeptide libraries , 1997, Nature Biotechnology.
[4] G. Winter,et al. Making antibodies by phage display technology. , 1994, Annual review of immunology.
[5] S L Morrison,et al. Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. , 1989, Journal of immunology.
[6] L. Simmons,et al. Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies. , 2002, Journal of immunological methods.
[7] G. Georgiou,et al. In vitro scanning saturation mutagenesis of all the specificity determining residues in an antibody binding site. , 1999, Protein engineering.
[8] Andreas Plückthun,et al. In-vitro protein evolution by ribosome display and mRNA display. , 2004, Journal of immunological methods.
[9] M. Uhlén,et al. A synthetic IgG-binding domain based on staphylococcal protein A. , 1987, Protein engineering.
[10] C. Milstein,et al. Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.
[11] G. Georgiou,et al. Development of an optimized expression system for the screening of antibody libraries displayed on the Escherichia coli surface. , 1999, Protein engineering.
[12] M. Berger,et al. Human antibodies for immunotherapy development generated via a human B cell hybridoma technology , 2006 .
[13] George Georgiou,et al. Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity , 2002, Nature Biotechnology.
[14] L. Jendeberg,et al. Kinetic analysis of the interaction between protein a domain variants and human Fc using plasmon resonance detection , 1995, Journal of molecular recognition : JMR.
[15] George Georgiou,et al. Anchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries. , 2004, Proceedings of the National Academy of Sciences of the United States of America.